Salute e Benessere
Esaote enters the field of neurosurgery by presenting an innovative intraoperative MRI system. I-Genius is the result of Esaote's research and collaboration with neurosurgeons.
VIENNA , Oct. 7, 2025 /PRNewswire/ -- a leading Italian innovator in medical imaging – ultrasound, dedicated magnetic resonance and medical IT – on the occasion of the 25 EANS - European Association of Neurosurgical Societies - Annual Congress held in Vienna on 5-9 October.
I-Genius has been developed by Esaote' Research and Development laboratories
, accounting for about 81 % of malignant intracranial tumours. The most frequent glioma subtype, glioblastoma, represents roughly 45 % of gliomas and has a five–year survival rate of only about 5 %. but when tumour tissue is difficult to distinguish from healthy brain tissue by the naked eye, .
Imaging techniques are used to identify residual tumour, but once the meninges are opened, and especially during tissue removal, the brain shifts. That shift causes loss of spatial coherence between preoperative and intraoperative imaging, which increases the chance that parts of the tumour are left behind. While ultrasound and CT are used intraoperatively, ultrasound has limited field of view, and CT involves repeated ionising radiation; MRI avoids both limitations. closed–magnet devices that are not only expensive to install and maintain but are very complex to be used during a surgery operation, either increasing the surgery time or exposing the patient to additional risks.
It is an The system includes The patient stays on the same table for the entire procedure and does not need to be move during the operation.
, helping surgeons to confirm that the tumour has been fully removed—before closing the skull.
This new solution was the focus of the Symposium " " hosted by Esaote at EANS.
Chief of Neurosurgery, Clinica Adventista Belgrano, Buenos Aires , said: "
" - said CEO of Esaote - "
Leader in medical imaging (ultrasound, MRI, software to manage the diagnostic process). At the end of 2024, the Group had approximately 1,300 employees, half of whom in Italy . Every year the company invests about 13% of its consolidated sales in R&D. With facilities in Genoa and Florence, and its own production and research units in Italy and the Netherlands , Esaote maintains a presence in over 100 countries around the world. www.esaote.com.
Photo - https://mma.prnewswire.com/media/2789443/FRANCO_FONTANA_I_GENIUS.jpg
Logo - https://mma.prnewswire.com/media/2789447/Esaote_logo.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/esaote-enters-the-field-of-neurosurgery-by-presenting-an-innovative-intraoperative-mri-system-igenius-is-the-result-of-esaotes-research-and-collaboration-with-neurosurgeons-302575737.html